English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduScientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.
Tag: Cancer Treatment
UNM Cancer Center Renews NCI Comprehensive Designation
The University of New Mexico Comprehensive Cancer Center has once again been awarded the highest designation and rating in the United States for cancer treatment and research programs.
Researchers developing new cancer treatments with high-intensity focused ultrasound
Researchers are bringing the use of acoustic waves to target and destroy cancerous tumours closer to reality.
Cancer treatment and research ‘brain gain’
Cancer patients will benefit from world-class research and new treatments with the appointment of three globally-lauded scientists to the University of Adelaide’s South Australian immunoGENomics Cancer Institute (SAiGENCI).
Cancer treatment and research ‘brain gain’
Cancer patients will benefit from world-class research and new treatments with the appointment of three globally-lauded scientists to the University of Adelaide’s South Australian immunoGENomics Cancer Institute (SAiGENCI).
Palliative Care for Cancer Patients: How does it Help?
For cancer patients undergoing treatments, palliative care can provide excellent pain and symptom management that can help them feel better. Palliative care experts at Rutgers Cancer Institute of New Jersey
answer common questions about how palliative care can enhance quality of life for patients to highlight palliative care and cancer pain awareness month.
Palliative Care for Cancer Patients: How does it Help?
For cancer patients undergoing treatments, palliative care can provide excellent pain and symptom management that can help them feel better. Palliative care experts at Rutgers Cancer Institute of New Jersey
answer common questions about how palliative care can enhance quality of life for patients to highlight palliative care and cancer pain awareness month.
New Imaging Isotope Meets Promising Therapy Isotopes
Researchers have demonstrated the production, purification, and potential application of cerium-134. The isotope decays into lanthanum-134, which is useful for positron emission tomography (PET) imaging. The results mean that cerium-134 could support medical treatments based on actinium-225 or thorium-227.
New Elegant Method for Rapid Recovery of Anti-Cancer Agent At-211
One isotope of the extremely rare element Astatine has shown promise in the treatment of malignant brain tumors, ovarian cancer, advanced blood and lymph system cancers. However, because of its short half-life, scientists need a rapid system with high yield to recover the isotope, At-211, for medical use. Scientists have developed a new purification system that results in a high purity, high yield recovery of At-211.
Protecting your Heart Before, During and After Cancer Treatment
Therapies such as chemotherapy, radiotherapy, immunotherapy and other novel targeted treatments that are used to combat many cancers have the potential to contribute to cardiac toxicity. Rutgers Cancer Institute expert sheds light on the field of Cardo-Oncology, which focuses on the prevention and treatment of cardiac-related issues in cancer patients.
Innovation in Cancer Prevention – Bio-robots Transporting Cordyceps Extract
Chula researchers celebrate the success of Active Targeting, a revolutionary innovation in the medical industry using bio–robots to deliver targeted cordyceps extract to halt cancer with reduced side effects.
First in the World! Chulalongkorn Hospital Successfully Treats a Breast Cancer Patient with Immunotherapy
Queen Sirikit Center for Breast Cancer, King Chulalongkorn Memorial Hospital, Thai Red Cross Society (Chulalongkorn Hospital) has become the world’s first institution to have successfully used immunotherapy to treat a breast cancer patient who is now in complete remission with minimal side effects and uplifted quality of life.
Study finds lasofoxifene a promising treatment for therapy-resistant breast cancer
In a study carried out in mice at the University of Chicago, researchers found that lasofoxifene outperformed fulvestrant, the current gold-standard drug, in reducing or preventing primary tumor growth.
New Research Suggests Breast Cancer Treatment in Patients over Age 70 Can Be Safely Reduced
Research indicates the rate of cancer recurrence or survival may be no different in older women diagnosed with early breast cancer whether they were treated or untreated.
ORNL meets key FDA milestone for cancer-fighting Ac-225 isotope
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs. The U.S. Food and Drug Administration recently received Oak Ridge National Laboratory’s drug master file for actinium-225 nitrate, which lets pharmaceutical companies reference the document to support applications for their own Ac-225-based drugs without disclosing proprietary information.
Fighting Cancer with DNA Origami
Scientists have devised a new way to build nanomaterials that can maintain their structural integrity and functionality in ways relevant to drug delivery. The team developed a class of molecular coatings compatible with biological environments. They used these coating to stabilize wireframed DNA origami cages that can carry an anticancer drug with a slower release of the medicine over time than possible with noncoated counterparts.
Cancer Patients Who Are Most Worried About Finances Shown to Have Worse Outcomes
Cancer treatment is likely to affect every aspect of a patient’s life — their activities, relationships, eating habits, mental health, physical health and comfort, financial wellbeing. And when financial concerns weigh heavily on an individual who is in treatment for cancer, they can affect the outcome of that treatment. New research from Roswell Park Comprehensive Cancer Center provides the first evidence that a cancer patient’s level of financial worry as they begin treatment predicts how likely it is that their treatment will be successful.
Memorial Cancer Institute Together with FAU Research Partnership Earn ‘Cancer Center of Excellence’ Designation
A research partnership formed just last year by Memorial Healthcare System and Florida Atlantic University is already being recognized for quality care, results, and advances in research, and that’s great news for patients fighting cancer in South Florida. The alliance between Memorial’s Cancer Institute and FAU (MCIFAU) has been recognized by the state’s Department of Health as a “Florida Cancer Center of Excellence.” It becomes just the fifth in the state, out of more than 80 competitors, to earn the designation.
Socioeconomic status plays a major role in cognitive outcomes
Childhood cancer and its treatment can result in cognitive struggles. St. Jude scientists are studying the risk factors.
From the clinic to the lab, understanding medulloblastoma relies on molecular profiling
A pair of research papers from St. Jude Children’s Research Hospital report on a medulloblastoma clinical trial that provides insights to guide treatment and shed light on relapsed disease.
UNH Researchers Discover New Inhibitor Drug Combination for Rare Form of Cancer
Waldenström macroglobulinemia (WM), a rare form of lymphoma, does not have any known cure and only one FDA-approved treatment making it challenging to treat patients. Researchers at the University of New Hampshire took the novel approach of targeting specific cell proteins that control DNA information using inhibitors, or drugs, that were effective in reducing the growth of the cancer cells and when combined with a third drug were even more successful in killing the WM cancer cells which could lead to more treatment options.
Scientists develop a cheaper method that might help create fuels from plants
Scientists have figured out a cheaper, more efficient way to conduct a chemical reaction at the heart of many biological processes, which may lead to better ways to create biofuels from plants.
Scientists Recruit New Atomic Heavyweights in Targeted Fight Against Cancer
Researchers from Berkeley Lab and Los Alamos National Laboratory have developed new methods for the large-scale production, purification, and use of the radioisotope cerium-134, which could serve as a PET imaging radiotracer for a highly targeted cancer treatment known as alpha-particle therapy.
Key Discoveries in Cancer Treatment to Be Presented During the Virtual 2020 AACC Annual Scientific Meeting
During the all-virtual 2020 AACC Annual Scientific Meeting & Clinical Lab Expo, leading scientific experts will dive into the groundbreaking advances that are the future of cancer care. One plenary session will focus on the cutting-edge treatment known as T cell therapy, while another will showcase recent discoveries about tumor metabolism that could lead to new, more effective cancer drugs.
Henry Ford Cancer Institute and United Outstanding Physicians Partner to Enhance Care, Experience for Cancer Patients
Henry Ford Cancer Institute and United Outstanding Physicians (UOP), a physician organization comprising nearly 1,000 independent private practice physicians across Southeast Michigan, have come together to enhance cancer care and make navigating the cancer journey easier for their patients.
Regular Exercise May Protect Cardiovascular Cells during Chemotherapy
Marie Mclaughlin, MSc, from Edinburgh Napier University in Scotland, will present research on human endothelial cells treated with FEC-T, a chemotherapy regimen that combines four drugs (5 fluorouracil, epirubicin, cyclophosphamide and docetaxel). The researchers found that preconditioning the endothelial cells with serum (blood) from people who habitually exercise caused less cell death than samples that were treated with untrained serum (people who exercised less than 75 minutes per week). “Exercise preconditioning can provide protection against these detrimental effects in vitro,” Mclaughlin explained.
Exercise May Improve Effects of Radiation Therapy in Prostate Cancer
Cancer is the second leading cause of death around the world after heart disease. This week, researchers exploring the effects of exercise as a natural preventive tool and noninvasive treatment for cancer will present their work at the American Physiological Society (APS) Integrative Physiology of Exercise conference.
Rutgers Finds New Way to Personalize Treatments for Prostate Cancer
Rutgers researchers have discovered human gene markers that work together to cause metastatic prostate cancer – cancer that spreads beyond the prostate.
New tools to improve care for cancer that has spread to the brain
The tools will help doctors and patients make better-informed treatment decisions, enhance the care of brain metastases, and enable hospitals to improve the coordination and effectiveness of their interdisciplinary treatment programs.
New nanotechology design provides hope for personalized vaccination for treating cancer
A new study demonstrates the use of charged nanoscale metal-organic frameworks for generating free radicals using X-rays within tumor tissue to kill cancer cells. The same frameworks can be used for delivering immune signaling molecules to activate the immune response against tumor cells.
Liver cancer treatment showing positive results, Tulane study says
A biomedical engineering research team from Tulane University is developing a novel cancer treatment hepatocellular carcinoma, a highly fatal form of liver cancer.
Half of breast cancer survivors had delays in care due to COVID-19
The results of an online questionnaire of 609 breast cancer survivors in the U.S. suggest that nearly half of patients experienced delays in care during the early weeks of the COVID-19 pandemic. The study, by researchers at the University of Illinois Chicago, is published in the journal Breast Cancer Research and Treatment.
Chasing the Dream
Ala Ebaid, MD, completed his fellowship in hematology/oncology at the UNM Cancer Center in June and begins clinical work in August. He’s been in New Mexico for a decade, and he says he doesn’t plan to leave any time soon.
Henry Ford Health System Kicks Off David DiChiera Music Therapy Program with Detroit Symphony Orchestra and Michigan Opera Theatre
Henry Ford Health System, in partnership with the Detroit Symphony Orchestra (DSO) and Michigan Opera Theatre (MOT), has begun offering virtual musical performances to cancer patients via its music therapy program named for the founding general director of Michigan Opera Theatre, David DiChiera. Through the David DiChiera Music Therapy Program, patients of Henry Ford Cancer Institute will be able to enjoy both live and archived virtual performances from the DSO and MOT at no cost.
Delay in breast cancer operations due to COVID-19 pandemic appears to be non-life-threatening for women with early-stage disease
A new breast cancer study brings reassuring findings for women with early-stage breast cancer who were forced to delay their cancer operations because of the Coronavirus Disease 2019 (COVID-19) pandemic.
Rutgers, DuPont Nutrition & Biosciences Announce Research Collaboration
The Rutgers Center for Advanced Biotechnology and Medicine and DuPont Nutrition & Biosciences have announced a new collaboration in the field of microbiome science they hope will improve cancer treatment.
100th Patient Receives Final Cancer Treatment With MRI-guided Radiation at Loyola Medicine
Loyola Medicine recently celebrated its 100th patient to complete cancer treatment with the MRIdian by Viewray radiation therapy system, a novel treatment that utilizes MRI-guided radiation to precisely treat cancerous tumors, typically with fewer treatment sessions and side effects, and better outcomes.
Brain Cancer: UVA IDs Gene Responsible for Deadly Glioblastoma
The discovery of the oncogene responsible for glioblastoma could be the brain tumor’s Achilles’ heel, one researcher says.
Bacteria in Cancer Cells May Help or Hinder Treatment
Weizmann Institute scientists show that bacteria live inside all cancer cells, from brain to breast to bone, and that each type of cancer has its own type of bacteria. Understanding this relationship could help predict treatment effectiveness or lead to ways of using the bacteria to boost treatments.
MSK: Cancer Isn’t Sheltering in Place
As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, Memorial Sloan Kettering Cancer Center oncologists are urging patients to schedule cancer screenings and treatments now – as the long-term toll of missed diagnoses and delayed treatments could be devastating for patients and their loved ones across the region and the country.
MD Anderson and Innovent Biologics announce a strategic collaboration to develop anti-PD-1 therapy TYVYT® (sintilimab injection) in rare cancers
MD Anderson and Innovent Biologics have announced a strategic collaboration agreement to co-develop Innovent’s anti-PD-1 monoclonal antibody for treating rare cancers in the U.S.
COPING AFTER BREAST CANCER
With $3.25 million in new funding from the National Institutes of Health (NIH), a University of Delaware team will examine how the fear of cancer recurrence affects the well-being and relationships of breast cancer patients and their spouses or partners.
New treatment extends lives of people with most common type of liver cancer
For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.
Angiotensin Hormone’s Protective Effects Could Improve Cancer Treatment
Article title: Angiotensin-(1–7) reduces doxorubicin-induced cardiac dysfunction in male and female Sprague-Dawley rats through antioxidant mechanisms Authors: Omeed Rahimi, Jay Kirby, Jasmina Varagic, Brian Westwood, E. Ann Tallant, Patricia E. Gallagher From the authors: “[Angiotensin]-(1–7) is a clinically safe peptide hormone with cardioprotective…
Combination of engineered cold sore virus and inhibitor drugs could destroy brain tumors
Researchers who discovered that an engineered cold sore virus could help destroy brain tumors from the inside out have determined a one-two punch might be the key to finish them off. This virotherapy could make a class of investigational cancer drugs more effective, according to investigators at UTHealth.
Amino Acid Supplement + Radiation for Cancer = A Dangerous Mix for Some
Research in mice suggests that supplementing the essential nutrient methionine combined with radiation therapy impairs gut function to promote a life-threatening form of radiation toxicity. The study highlights the importance of food and nutrition professionals as part of a cancer treatment team.
Amino Acid Supplement + Radiation for Cancer = A Dangerous Mix for Some
Article title: Methionine dietary supplementation potentiates ionizing radiation-induced gastrointestinal syndrome Authors: Isabelle R. Miousse, Laura E. Ewing, Charles M. Skinner, Rupak Pathak, Sarita Garg, Kristy R. Kutanzi, Stepan Melnyk, Martin Hauer-Jensen, Igor Koturbash From the authors: “This study demonstrates that dietary…
A New Outline of Cancer Therapies for Patients
Professor Yuval Shaked, head of the Technion Integrated Cancer Center, presents an outline for therapy that will prevent the development of cancer treatment resistance, with suggestions about how the information can be used clinically.
Grant to help UniSA researchers develop personalised cancer treatment
Personalised cancer treatment is one step closer to becoming a reality for more patients, thanks to a Cancer Council Beat Cancer Project grant awarded to University of South Australia researcher Dr Stephanie Reuter Lange to explore how computer-based modelling can optimise cancer treatment and remove the need for expensive clinical trials.
Study finds salt nanoparticles are toxic to cancer cells
A new study at the University of Georgia has found a way to attack cancer cells that is potentially less harmful to the patient.